True about antiphospholipid antibody syndrome include following –
The correct answer options would typically include things like recurrent arterial or venous thrombosis, pregnancy morbidity, and the presence of specific antibodies like lupus anticoagulant or anti-cardiolipin. I need to make sure the correct answer includes these elements.
Now, for the wrong options, common distractors might be other autoimmune conditions, like systemic lupus erythematosus (SLE), or incorrect associations such as linking APS with bleeding disorders instead of thrombosis. Another possible wrong option could be incorrect diagnostic criteria, like using a single antibody test instead of repeated testing.
The clinical pearl here is to remember that APS is diagnosed based on clinical criteria and confirmed by laboratory tests done on two separate occasions, at least 12 weeks apart. Also, patients often present with thrombotic events in unusual locations, such as the cerebral veins.
I should structure the explanation with the core concept first, then explain why the correct answer is right, address each wrong option, and end with a high-yield fact. Need to keep each section concise and use proper medical terminology. Let me check if I missed any key points, like the role of beta-2 glycoprotein I in antibody binding. Also, mention that APS can be primary or secondary (like in SLE). Make sure the explanation is thorough but within the character limit.
**Core Concept**
Antiphospholipid antibody syndrome (APS) is an autoimmune disorder defined by recurrent thrombosis (arterial/venous) or pregnancy complications (e.g., fetal loss, preeclampsia) in association with persistent antiphospholipid antibodies (aPLs). Key antibodies include lupus anticoagulant (LA), anti-cardiolipin, and anti-β2-glycoprotein I. Diagnosis requires both clinical and laboratory criteria confirmed on **two separate occasions ≥12 weeks apart**.
**Why the Correct Answer is Right**
The correct option includes **recurrent thrombosis in unusual sites** (e.g., cerebral veins, retinal arteries) and **pregnancy complications** as hallmark features. aPLs bind to phospholipid-bound β2-glycoprotein I, triggering endothelial damage, complement activation, and hypercoagulability. LA prolongs clotting time *in vitro* but causes thrombosis *in vivo*, while anti-cardiolipin antibodies correlate with miscarriage risk. Diagnosis requires **persistent positivity** of aPLs to exclude transient states (e.g., infections, drugs).
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it states "bleeding diathesis" – APS causes thrombosis, not bleeding.
**Option B:** Incorrect if it mentions "positive ANA as diagnostic" – ANA is part of SLE criteria, not APS.
**Option C:** Incorrect if it claims "single aPL test suffices" – requires confirmation ≥12 weeks apart.
**Option D:** Incorrect if it lists "